Literature DB >> 8943715

Enhancement of CD3-mediated thymocyte apoptosis by the cross-linkage of heat-stable antigen.

Y Hitsumoto1, D S Song, M Okada, F Hamada, S Saheki, N Takeuchi.   

Abstract

Heat-stable antigen (HSA) is a murine differentiating antigen that is expressed on both CD4-CD8- double-negative and CD4+CD8+ double-positive thymocytes but not CD4+ or CD8+ single-positive thymocytes. Effects of anti-HSA monoclonal antibody, R13, on thymocyte apoptosis induced by various stimulations were investigated by a single-cell suspension culture system. Immobilized R13 enhanced the CD3-mediated DNA fragmentation and killing of thymocytes but not the dexamethasone-induced or phorbol myristate acetate-induced killing of thymocytes. Immobilized R13 by itself could not induce thymocyte apoptosis. Soluble R13 enhanced CD3-mediated apoptosis when HSA and T-cell receptor (TCR)/CD3 were co-cross-linked by a cross-reactive secondary antibody. Even without the cross-reactive secondary antibody, soluble R13 enhanced CD3-mediated apoptosis, although a greater than 100-fold increase in the amount of R13 was needed to give a similar enhancement compared with immobilized R13. Neither R13 by itself nor R13 plus secondary antibody induced cytosolic calcium influx, whereas R13 enhanced CD3-mediated cytosolic calcium increase. These results suggest a functional role of HSA in promoting the activation-induced apoptosis of thymocytes and the involvement of HSA in negative selection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943715      PMCID: PMC1456481          DOI: 10.1046/j.1365-2567.1996.d01-741.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures.

Authors:  C A Smith; G T Williams; R Kingston; E J Jenkinson; J J Owen
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

2.  Simple and rapid fluorimetric method for DNA microassay.

Authors:  J Kapuściński; B Skoczylas
Journal:  Anal Biochem       Date:  1977-11       Impact factor: 3.365

3.  Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage.

Authors:  B J Fowlkes; R H Schwartz; D M Pardoll
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

4.  Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Authors:  O Leo; M Foo; D H Sachs; L E Samelson; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

Review 6.  The developmental biology of T lymphocytes.

Authors:  H von Boehmer
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

7.  Intrathymic deletion of self-reactive cells prevented by neonatal anti-CD4 antibody treatment.

Authors:  H R MacDonald; H Hengartner; T Pedrazzini
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

8.  Hematopoietic subpopulations express cross-reactive, lineage-specific molecules detected by monoclonal antibody.

Authors:  F W Symington; S Hakomori
Journal:  Mol Immunol       Date:  1984-06       Impact factor: 4.407

9.  A monoclonal antibody discriminating between subsets of T and B cells.

Authors:  J Bruce; F W Symington; T J McKearn; J Sprent
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

10.  A role for CD5 in TCR-mediated signal transduction and thymocyte selection.

Authors:  A Tarakhovsky; S B Kanner; J Hombach; J A Ledbetter; W Müller; N Killeen; K Rajewsky
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  1 in total

1.  Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized mice.

Authors:  Chelsea M Black; Todd D Armstrong; Elizabeth M Jaffee
Journal:  Cancer Immunol Res       Date:  2014-01-17       Impact factor: 11.151

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.